Utilization and adverse outcomes of percutaneous left atrial appendage closure for stroke prevention in atrial fibrillation in the United States: influence of hospital volume
- PMID: 25480543
- DOI: 10.1161/CIRCEP.114.001413
Utilization and adverse outcomes of percutaneous left atrial appendage closure for stroke prevention in atrial fibrillation in the United States: influence of hospital volume
Abstract
Background: Safety data on percutaneous left atrial appendage closure arises from centers with considerable expertise in the procedure or from clinical trial, which might not be reproducible in clinical practice. We sought to estimate the frequency and predictors of adverse outcomes and costs of percutaneous left atrial appendage closure procedure in the US.
Methods and results: The data were obtained from the Nationwide Inpatient Sample from the years 2006 to 2010. The Nationwide Inpatient Sample is the largest all-payer inpatient data set in the US. Complications were calculated using patient safety indicators and International Classification of Diseases-Ninth Revision, Clinical Modification codes. Annual hospital volume was calculated using unique hospital identifiers. Weights provided by the Nationwide Inpatient Sample were used to generate national estimates. A total of 268 (weighted=1288) procedures were analyzed. The overall composite rate of mortality or any adverse event was 24.3% (65), with 3.4% patients required open cardiac surgery after procedure. Average length of stay was 4.61±1.05 days and cost of care was 26,024±34,651. Annual hospital procedural volume was significantly associated with reduced complications and mortality (every unit increase: odds ratio, 0.89; 95% confidence interval, 0.85-0.94; P<0.001), decrease in length of stay (every unit increase: hazard ratio, 0.95; 95% confidence interval, 0.92-0.98; P<0.001) and cost of care (every unit increase: hazard ratio, 0.96; 95% confidence interval, 0.93-0.98; P<0.001).
Conclusions: Our study demonstrates that the frequency of inhospital adverse outcomes associated with percutaneous left atrial appendage closure is higher in the real-world population than in clinical trials. We also demonstrate that higher annual hospital volume is associated with safer procedures, with lower length of stay and cost.
Keywords: atrial fibrillation; left atrial appendage; percutaneous closure; stroke prevention.
© 2014 American Heart Association, Inc.
Comment in
-
Left atrial appendage closure for stroke prevention in atrial fibrillation: response to an unmet need with an unclear direction.Circ Arrhythm Electrophysiol. 2015 Feb;8(1):8-10. doi: 10.1161/CIRCEP.115.002634. Circ Arrhythm Electrophysiol. 2015. PMID: 25691551 No abstract available.
Similar articles
-
The budget impact of left atrial appendage closure compared with adjusted-dose warfarin and dabigatran etexilate for stroke prevention in atrial fibrillation.Europace. 2014 Aug;16(8):1131-6. doi: 10.1093/europace/euu038. Epub 2014 Mar 30. Europace. 2014. PMID: 24687964
-
Influence of hospital volume on outcomes of percutaneous atrial septal defect and patent foramen ovale closure: a 10-years US perspective.Catheter Cardiovasc Interv. 2015 May;85(6):1073-81. doi: 10.1002/ccd.25794. Epub 2015 Feb 3. Catheter Cardiovasc Interv. 2015. PMID: 25534392
-
Safety of percutaneous left atrial appendage closure with the Amplatzer cardiac plug in patients with atrial fibrillation and contraindications to anticoagulation.Catheter Cardiovasc Interv. 2014 Apr 1;83(5):796-802. doi: 10.1002/ccd.25329. Epub 2014 Jan 8. Catheter Cardiovasc Interv. 2014. PMID: 24327462
-
Percutaneous left atrial appendage closure: procedural techniques and outcomes.JACC Cardiovasc Interv. 2014 Nov;7(11):1205-20. doi: 10.1016/j.jcin.2014.05.026. Epub 2014 Nov 17. JACC Cardiovasc Interv. 2014. PMID: 25459035 Review.
-
Left atrial appendage closure.Prog Cardiovasc Dis. 2015 Sep-Oct;58(2):195-201. doi: 10.1016/j.pcad.2015.07.009. Epub 2015 Aug 1. Prog Cardiovasc Dis. 2015. PMID: 26241302 Review.
Cited by
-
Percutaneous left atrial appendage occlusion and risk of stroke, hospitalized bleeding and death in Medicare beneficiaries.Pharmacoepidemiol Drug Saf. 2024 Apr;33(4):e5786. doi: 10.1002/pds.5786. Pharmacoepidemiol Drug Saf. 2024. PMID: 38565524
-
Catheter based left atrial appendage closure in-hospital outcomes in Germany from 2016 to 2020.Clin Res Cardiol. 2024 Oct;113(10):1419-1429. doi: 10.1007/s00392-023-02299-w. Epub 2023 Sep 12. Clin Res Cardiol. 2024. PMID: 37698619 Free PMC article.
-
Less major bleeding and higher hemoglobin after left atrial appendage closure in high-risk patients: Data from a long-term, longitudinal, two-center observational study.Clin Cardiol. 2023 Nov;46(11):1337-1344. doi: 10.1002/clc.24123. Epub 2023 Aug 13. Clin Cardiol. 2023. PMID: 37573576 Free PMC article.
-
Safety and Healthcare Resource Utilization in Patients Undergoing Left Atrial Appendage Closure-A Nationwide Analysis.J Clin Med. 2023 Jul 9;12(14):4573. doi: 10.3390/jcm12144573. J Clin Med. 2023. PMID: 37510689 Free PMC article.
-
Left Atrial Appendage Closure Device Embolization under the Anterior Leaflet of Mitral Valve: Echocardiographic Diagnosis and Management.J Cardiovasc Echogr. 2023 Jan-Mar;33(1):40-42. doi: 10.4103/jcecho.jcecho_56_22. Epub 2023 May 29. J Cardiovasc Echogr. 2023. PMID: 37426718 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
